| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1755-3768.2010.01982.X |
| P8608 | Fatcat ID | release_fdkvwjduonekfb3tcbpo7nwayy |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2010.01982.x |
| https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1755-3768.2010.01982.x | ||
| http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2010.01982.x/fullpdf | ||
| P698 | PubMed publication ID | 20738260 |
| P5875 | ResearchGate publication ID | 45950537 |
| P50 | author | Jost B Jonas | Q48356058 |
| P2093 | author name string | Rutledge Ellis-Behnke | |
| P2860 | cites work | Safety and efficacy of gene transfer for Leber's congenital amaurosis | Q24634724 |
| Drug delivery and nanoparticles:applications and hazards | Q24655744 | ||
| Effect of gene therapy on visual function in Leber's congenital amaurosis | Q28277981 | ||
| Bcl-2 promotes regeneration of severed axons in mammalian CNS | Q28504892 | ||
| Tissue engineering | Q29617288 | ||
| Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
| Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. | Q30476979 | ||
| Intravitreal injection of triamcinolone for diffuse diabetic macular edema | Q30881071 | ||
| The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. | Q30988191 | ||
| Brain cancer diagnosis and therapy with nanoplatforms | Q31077438 | ||
| Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study | Q31148660 | ||
| Axon resealing following transection takes longer in central axons than in peripheral axons: implications for axonal regeneration | Q31848537 | ||
| Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. | Q33193314 | ||
| Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. | Q33207041 | ||
| Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys | Q33219678 | ||
| Cell delivery in regenerative medicine: the cell sheet engineering approach | Q33252967 | ||
| Efficient non-viral ocular gene transfer with compacted DNA nanoparticles | Q33267297 | ||
| Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins. | Q33322997 | ||
| Prospects for nanomedicine in treating age-related macular degeneration | Q33424022 | ||
| Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation | Q33772519 | ||
| Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery | Q33932473 | ||
| Re-establishing the regenerative potential of central nervous system axons in postnatal mice | Q34313677 | ||
| Nanomedicine: current status and future prospects. | Q34399915 | ||
| Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants | Q34410761 | ||
| Nanoscale engineering of biomimetic surfaces: cues from the extracellular matrix | Q34613616 | ||
| Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans | Q34768907 | ||
| Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). | Q34785020 | ||
| Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect | Q35025058 | ||
| Stem cells as tools in regenerative therapy for retinal degeneration | Q35335016 | ||
| Vesicular systems in ocular drug delivery: an overview | Q35617707 | ||
| Cell transplantation strategies for retinal repair. | Q35737835 | ||
| Exploring RPE as a source of photoreceptors: differentiation and integration of transdifferentiating cells grafted into embryonic chick eyes | Q35792412 | ||
| Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. | Q35885116 | ||
| Approaches to neural tissue engineering using scaffolds for drug delivery | Q35990610 | ||
| Application of encapsulated cell technology for retinal degenerative diseases | Q36521847 | ||
| Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells | Q36606861 | ||
| Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer | Q36733028 | ||
| Matrices and scaffolds for DNA delivery in tissue engineering | Q36826532 | ||
| Using nanotechnology to design potential therapies for CNS regeneration | Q36907506 | ||
| Nanoparticles in modern medicine: state of the art and future challenges | Q36920457 | ||
| Nano neurology and the four P's of central nervous system regeneration: preserve, permit, promote, plasticity | Q36934340 | ||
| Stem cells of the adult cornea: from cytometric markers to therapeutic applications | Q37339936 | ||
| Design of multifunctional nanomedical systems | Q37377644 | ||
| Nanobiosystems | Q37668381 | ||
| Applications of nanobiotechnology in ophthalmology--Part I. | Q37687041 | ||
| Intravitreal cell-based production of glucagon-like peptide-1. | Q39491387 | ||
| Using Self-Assembled Nanomaterials to Inhibit the Formation of Metastatic Cancer Stem Cell Colonies in Vitro | Q39649098 | ||
| Drug carrier systems based on collagen-alginate composite structures for improving the performance of GDNF-secreting HEK293 cells. | Q39908309 | ||
| Rapid and stable knockdown of an endogenous gene in retinal pigment epithelium | Q40076885 | ||
| Temperature and pH effects on biophysical and morphological properties of self-assembling peptide RADA16-I. | Q40134145 | ||
| Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). | Q40196371 | ||
| Nano hemostat solution: immediate hemostasis at the nanoscale. | Q40243410 | ||
| Transplantable retinal pigment epithelial cell sheets for tissue engineering. | Q40303102 | ||
| Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs | Q40445384 | ||
| Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device. | Q40463263 | ||
| Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells | Q40555161 | ||
| Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells | Q40618965 | ||
| Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression | Q40668704 | ||
| Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema | Q42116404 | ||
| Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells | Q43680843 | ||
| Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism | Q44265567 | ||
| A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results | Q44438397 | ||
| Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD. | Q44459863 | ||
| Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. | Q44526900 | ||
| Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration | Q44760308 | ||
| Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits. | Q44874891 | ||
| Fullerene nanomaterials inhibit the allergic response | Q44930331 | ||
| Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study | Q44952432 | ||
| Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology | Q44956668 | ||
| Pegaptanib for neovascular age-related macular degeneration | Q45206481 | ||
| Growth factor-responsive progenitors in the postnatal mammalian retina | Q45215174 | ||
| Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity. | Q45885254 | ||
| Distribution of Müller stem cells within the neural retina: evidence for the existence of a ciliary margin-like zone in the adult human eye. | Q46044177 | ||
| Induction of retinal pigment epithelium properties in ciliary margin progenitor cells | Q46431542 | ||
| Forever young: how to control the elongation, differentiation, and proliferation of cells using nanotechnology. | Q48365611 | ||
| Neurobiology of the regenerating retina and its functional reconnection with the brain by means of peripheral nerve transplants in adult rats. | Q48461647 | ||
| Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury | Q48501651 | ||
| Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. | Q50659784 | ||
| A pilot study investigating a novel subcutaneously implanted pre-cellularised scaffold for tissue engineering of intestinal mucosa. | Q51279301 | ||
| Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. | Q51305265 | ||
| Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells. | Q55407543 | ||
| Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity | Q57951216 | ||
| The clearance of intravitreal triamcinolone acetonide | Q70327960 | ||
| Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption | Q73367861 | ||
| Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis | Q80219462 | ||
| Intraocular cell-based production of glucagon-like peptide-1 in the anterior chamber | Q94946654 | ||
| Endophthalmitis after intravitreal injection of triamcinolone acetonide | Q95790295 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanomedicine | Q261659 |
| tissue engineering | Q1540285 | ||
| P304 | page(s) | e108-14 | |
| P577 | publication date | 2010-08-25 | |
| P1433 | published in | Acta Ophthalmologica | Q15716498 |
| P1476 | title | Redefining tissue engineering for nanomedicine in ophthalmology | |
| P478 | volume | 89 |
Search more.